Trimarchi Thomas — SEC Form 4 filings
SEC reporting owner CIK 2030813. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-08-08 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 5 filings — 103,775 shares, $5,991,774 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 42,237 shares @ $49.48 ($2,090,081) in BridgeBio Pharma, Inc., filed 2025-08-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | President and CFO | 15 | — | 9 legs · 103,775 sh · $5,991,774 | 15 |
Form 4 filings — Trimarchi Thomas
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 22,781 @ $79.86 | EDGAR |
| 2026-05-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 22,781 @ $66.13 · Sale (S): 10,456 @ $64.82 · Sale (S): 3,195 @ $65.95 | EDGAR |
| 2026-03-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 59,041 @ $0 | EDGAR |
| 2026-02-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 18,819 @ $75.25 · Sale (S): 13,400 @ $74.71 · Sale (S): 200 @ $75.38 | EDGAR |
| 2025-12-16 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 13,826 @ $75.15 | EDGAR |
| 2025-11-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 21,317 @ $66.39 · Sale (S): 9,978 @ $66.19 · Sale (S): 6,956 @ $66.84 | EDGAR |
| 2025-08-22 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 42,237 @ $49.48 | EDGAR |
| 2025-08-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 21,317 @ $51.32 · Sale (S): 15,380 @ $50.14 · Sale (S): 1,973 @ $50.94 | EDGAR |
| 2025-05-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 21,317 @ $33.84 | EDGAR |
| 2025-03-21 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 109,100 @ $0 | EDGAR |
| 2025-02-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 13,782 @ $34.90 | EDGAR |
| 2024-12-12 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-11-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 17,936 @ $23.72 | EDGAR |
| 2024-08-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 17,936 @ $24.40 | EDGAR |
| 2024-08-08 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 19,003 @ $0 · Grant/award (A): 3,160 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2030813 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →